SEC Form 4 · accession 0001127602-19-005984
LABCORP HOLDINGS INC. · LH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John D Ratliff
Officer — CEO, Covance Drug Development
Period of report
Feb 12, 2019
Accepted (ET)
Feb 14, 2019 · 4:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920148
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 12, 2019 | M | 1,463 | — | A | 16,255 | D | |
| Common Stock | Feb 12, 2019 | F | 654 | $146.59 | D | 15,601 | D | |
| Common Stock | holding | — | — | — | 40 | I | By revocable trust | |
| Common StockF3 | holding | — | — | — | 80 | I | By irrevocable trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF5,F1,F4 | — | Feb 12, 2019 | M | 1,463 | D | — | — | Common Stock | 1,463 | 16,911 | D |
| Restricted Stock UnitF5,F1,F6 | — | Feb 12, 2019 | A | 5,300 | A | — | — | Common Stock | 5,300 | 22,211 | D |
| Non-qualified Stock OptionsF7,F8 | $146.59 | Feb 12, 2019 | A | 21,800 | A | Feb 12, 2020 | Feb 11, 2029 | Common Stock | 21,800 | 21,800 | D |
Explanation of responses
- F1Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
- F2Stock withholding to satisfy tax withholding obligations.
- F3The reporting person is not a trustee of the irrevocable trust and disclaims beneficial ownership of the shares.
- F4The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/12/19.
- F5This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
- F6The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2020.
- F7Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
- F8The option vests in three equal installments beginning on the date reflected in this column.